Itaconix expects full-year revenue of no less than $14.8m, ahead of analyst forecasts of $13.3m, after delivering a record first half with revenues up 72% year-on-year to $8.3m.
The plant-based speciality polymers maker grew across all major product segments, and investors should be pleased to see sales up 46% on the second half of last year.
Gross margin is expected to hold at 36%, in line with 2025, following robust management of raw materials and supply chains.
Performance Ingredients, which primarily serves the dish detergent market, performed well in both EMEA and North America, helped by strong reorder volumes from existing customers plus new unit-dose dish and laundry detergent customer wins. SPARX Formulated Solutions grew on increased use of its formulations in North American solid unit-dose detergents.
The AIM-listed company is also advancing longer-term opportunities with its BIO*Asterix speciality monomers and binders for high-value paints, and its new BioVail plant-nutrition ingredient for crop production.
While cautioning that reorder rates are not yet firmly established, the board continues to expect a small positive EBITDA for the year, reflecting strategic investments in headcount and product development. Interim results are due around 8 September.
Itaconix shares rose 6% on Friday on the news.